<DOC>
	<DOCNO>NCT02804152</DOCNO>
	<brief_summary>Pregnant woman use prescription opioid medication ( pain medication ) invite take part program reduction pain prescription opioid misuse .</brief_summary>
	<brief_title>Program Pain &amp; Prescription Opioid Use Pregnancy</brief_title>
	<detailed_description>Subjects : Participants 200 adult , pregnant woman receive prenatal care use POs chronic pain . Women must willing consider PO dose reduction , meet criterion Substance Use Disorder . Specific inclusion exclusion criterion find Protections Human Subjects section . Procedures : Pregnant woman use POs identify obstetric care team , self-referred via study advertisement , refer study personnel . The obstetric care team serve referral source take part research related activity . Women schedule meet study personnel either in-person , via telemedicine phone undergo brief eligibility screening . If woman eligible give full description study procedure ask read sign IRB-approved consent form in-person consent online study procedures assessment conduct use doxyme software . Ineligible woman , want take part refer clinical treatment in-person via telemedicine . Baseline Visit : Eligible participant complete online assessment ( see primary outcome assessment ) via Redcap survey . They cell phone register daily diary system describe give instruction respond daily query regard pain , functioning , crave , mood etc . Participants without cell phone provide cell phone use study . Eligible participant complete daily rating 21 day . Treatment Phase : Immediately follow 21 day data collection phase , subject take part 8 , 75-minute session modify , individual CBT Chronic Pain program . This treatment deliver weekly 8 week study therapist . Participants continue daily diary rating review study therapist participant week therapy session . Subjects receive CBT service study . All service receive ( e.g. , pain management , self-help group , case management ) carefully monitor tracked weekly visit . Each week , follow CBT Chronic Pain session , participant meet study physician APRN , 15 minute . PO use review , symptom maternal fetal withdrawal assess ( see Safety Measures Appendix medication management session ) base participant 's preference , provider continue prescribe regime PO medication ( ) decrease overall dose 20 % - safe recommended reduction opioid medication pregnancy14 . Participant rational individual decision record appropriate amount PO medication prescribe in-person provider via telemedicine , collaboration in-person obstetric provider . Use POs provider carefully monitor tracked weekly visit use Prescription Drug Monitoring Program ( PDMP ) database review EMR ( see Safety Measures ) . Following weekly treatment session , participant complete online assessment ( see primary outcome assessment ) via Redcap survey . Follow-up : Women ask continue daily rating one month complete 8 week treatment . They also ask complete online assessment ( see primary outcome assessment ) via Redcap survey one month post-treatment . At 6 week postpartum , woman ask complete final online assessment ( see primary outcome assessment ) via Redcap survey .</detailed_description>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Adult female , race ethnicity , age 1845 year . Pregnant receive prenatal care Willing consider decrease dose prescription opioid medication . Does meet DSMV criterion Substance Use Disorder . Able comprehend English . Able provide inform consent . Unable provide inform consent . Not currently pregnant , receive prenatal care Not currently take prescription opioid medication pregnancy . Unwilling consider reduction prescription opioid medication dose . Meets DSMV criterion Substance Use Disorder . Participation recommend participant 's primary obstetrician</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>pain</keyword>
	<keyword>prescription opioid</keyword>
</DOC>